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Translocation of Pseudomonas aeruginosa through epithelial tissues can cause sepsis. Here, we
examined whether P. aeruginosa penetrates epithelial cell layers using type IV pili (TFP). Deletion
of TFP (pilA) did not affect association with Caco-2 cells, although it decreased penetration through,
and disruption of, Caco-2 cell monolayers. We found that TFP are necessary for injection of the type
III effector ExoS, which impairs defense against P. aeruginosa penetration, into host cells. Deletion of
pilA attenuated oral infection in silkworms. We conclude that P. aeruginosa injects ExoS into cells
through the function of TFP, enabling penetration of epithelial barriers.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Pseudomonas aeruginosa is a major opportunistic pathogen
that causes pneumonia and bacteremia, both of which are associ-
ated with high mortality rates and are often difﬁcult to treat in
immunocompromised patients [1,2]. P. aeruginosa colonization
of the respiratory, urinary and gastrointestinal tracts in immuno-
compromised patients can trigger a wide range of severe acute
and chronic complications in intensive care units (ICUs) [3]. In
a hospital, typical environmental reservoirs include basins, show-
ers and the rinsing water of manually prepared bronchoscopes
[4]. In addition, the gastrointestinal tract is considered an
endogenous reservoir for P. aeruginosa in immunocompromised
patients, and translocation of the colonized P. aeruginosa from
the gastrointestinal tract can cause severe bacteremia leadingto fatal sepsis [3–7]. Additionally, in vivo experiments using neu-
tropenic mice highlighted the importance of the translocation of
P. aeruginosa from the colonized gastrointestinal tract in cases of
severe sepsis [8,9]. Collectively, these reports suggest that the
elucidation of the translocation mechanisms of P. aeruginosa from
the gastrointestinal tract is required for a better understanding of
P. aeruginosa opportunistic infections.
To translocate to the blood from a host lumen, bacteria must
cross two major barriers, the mucous and epithelial cell layers
[10–12]. Epithelial cells, including those from the gastrointestinal,
respiratory and urinary tracts, attach to adjacent cells via tight
junctions, adherens junctions and desmosomes [13]. Tight junc-
tions provide barriers to prevent leakage of molecules, including
integral proteins and lipids, across the epithelia through the gaps
between cells [13]. Three distinct types of transmembrane pro-
teins have been localized to tight junctions; occludin [14], clau-
dins [15], and junctional adhesion molecules [16]. The lethal
effects of intestinal P. aeruginosa are dependent on its ability to
adhere to and disrupt epithelial cell layers [17–19]. We consider
that penetration of P. aeruginosa through the epithelial cell layer
is at least a ﬁve-step process involving: (i) recognition of epithe-
lial cells; (ii) access to epithelial cells; (iii) adhesion to epithelial
cells; (iv) formation of permeation route and (v) migration to a
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nosa can penetrate the mucin layer using ﬂagellar motility and
mucin degradation [20]. We have also recently demonstrated
that the type III effector molecule ExoS facilitates P. aeruginosa
penetration through the epithelial barrier by impairing the
defense function of tight junction proteins, including occludin,
against bacterial penetration [17]. However, it remains unclear
how P. aeruginosa, which has penetrated the mucus layer, then
adheres to and injects the ExoS effectors into intestinal epithelial
cells.
P. aeruginosa has two major structures that contribute to moti-
lity and adhesion: the ﬂagella [21,22] and type IV pili (TFP) [23–
25]. P. aeruginosa exhibits twitching motility, a form of transloca-
tion on a solid surface dependent on TFP [23]. This twitching moti-
lity derives from retraction of the ﬁlament, which mainly consists
of the major pilus subunit protein PilA, or pilin [23,26,27]. PilT and
PilU are PilB-like ATPases required for pilus retraction [28,29].
Deletion of the pilA gene reduces the association of P. aeruginosa
with, and cytotoxicity to, human respiratory epithelial cells
[22,30,31] and rabbit corneal epithelial cells [32]. Furthermore,
the C-terminal region of pilin binds to Galb1-4GlcNAa of asialo-
GM1 expressed by human respiratory epithelial cells
[24,25,30,33]. However, the role of TFP in the penetration of P. aer-
uginosa through the intestinal epithelial cell barrier is currently
unclear. Therefore, in the present study we examined whether P.
aeruginosa penetrates the epithelial cell monolayer through the
function of TFP.2. Materials and methods
2.1. Bacterial strains, plasmids and growth conditions
The P. aeruginosa wild-type strain PAO1 [34], and mutant
strains DexoS [17], DﬂiC [20], DpilA [35], and DpilA/pilA [35] are
our laboratory stock strains. The pilA and exoS double mutant strain
(DpilADexoS) was constructed by insertion of DpilA-pEX18Tc into
the DexoS strain [35]. A constructed pExoS-bla plasmid was
modiﬁed from that reported previously [36]. Brieﬂy, the promoter
region and the GAP-encoding region of the exoS gene were
PCR-ampliﬁed with primers BamHI-exoS (50-GCGCGGATCCACCTG
CAGGCTGAGTACGCTCTCCTCG-30) and exoS-Fu (50-TTTCTGGG
TGTCTAGACACTTCGGCGTCACTGTGGATGCCACC-30). The bla gene
was ampliﬁed from pGEX6P-1 (GE Healthcare, Waukesha, WI,
USA) with primers bla-Fu (50-CGCCGAAGTGTCTAGACACCCAGAA
ACGCTGGTGAAAGTAAAAG-30) and EcoR1-bla (50-ATATGAATTCT
TACCAATGCTTAATCAGTGAGGCACC-30). These two ﬂanking
sequences were joined by fusion PCR using primers BamHI-exoS
and EcoR1-bla containing the engineered restriction sites BamHI
and EcoRI. To obtain the ExoS-Bla fusion protein expression plas-
mid, the BamHI-exoS-bla-EcoRI fragment was ligated into the
BamHI-EcoRI fragment of pME6032 [37].
2.2. Antibodies
Anti-PilA polyclonal antibody was obtained from Scrum (Scrum,
Tokyo, Japan) [35]. Anti-occludin antibody was obtained from
Invitrogen (Life Technologies, Carlsbad, CA, USA). Anti-b-actin anti-
body was obtained from Chemicon (Merck Millipore, Billerica, MA,
USA).
2.3. Bacterial penetration assay
We carried out a Caco-2 cell monolayer penetration assay as
previously described [17]. Penetration by each strain was analyzed
in triplicate and the experiment was replicated in triplicate.2.4. Bacterial association assay
The assay was performed as reported previously [20]. Cellular
association for each strain was analyzed in triplicate and the
experiment was carried out in triplicate.
2.5. Expression of occludin protein in Caco-2 cell monolayers
The assay was performed as reported previously [17]. The pres-
ence of occludin in the samples was detected by Western blot ana-
lysis using anti-occludin (Life Technologies) and goat anti-rabbit
IgG-peroxidase conjugated antibodies (Sigma, St. Louis, MO,
USA). The bound antibodies were then visualized with the ECL
prime Western blotting detection system (GE Healthcare).
2.6. Mucin penetration assay
We carried out an artiﬁcial mucin penetration assay as
described previously [20]. Penetration of each strain was analyzed
in triplicate and the experiment was replicated in triplicate.
2.7. CCF2-AM loading and b-lactamase detection
The assay was modiﬁed from a previously reported method
[36]. Brieﬂy, HeLa cells were seeded at 1  104 cells per well in a
96-well plate and incubated at 37 C in 5% CO2 for 2 days.
Bacteria were inoculated at 1  106 CFUs per well. Following bac-
terial infection for 4 h, cells were washed six times with DPBS
and incubated with freshly prepared CCF2-AM solution (1 lM ﬁnal
concentration; Invitrogen, Life Technologies) for 1 h in the dark at
room temperature. Green ﬂuorescence of the uncleaved substrate
with an excitation wavelength of 410 nm and emission detection
at 530 nm and blue ﬂuorescence of the cleaved substrate with an
excitation wavelength of 410 nm and emission detection at
450 nmwere measured using a Varioskan™microtiter plate reader
(Thermo Scientiﬁc, Waltham, MA, USA). Cells were also observed
using an IX-71 ﬂuorescent microscope (Olympus, Tokyo, Japan).
The data presented are the means ± standard deviations of three
independent experiments.
2.8. Silkworm bacterial infection model
The assay was performed as reported previously [17]. In the oral
infection model, 10 silkworms (Bombyx mori, Hu-Yo  Tukuba-Ne)
at the ﬁfth-instar stage were fed an antibiotic-free artiﬁcial food,
Silkmate (an approximately 1.0 cm3 block; Katakura Industries,
Japan), to which 200 ll of a bacterial culture (1010 CFU/ml) grown
overnight had been added. As a negative control, 200 ll of saline
was added. The silkworms were maintained without food, and sur-
vival was monitored for 5 days. After infection for 6 h, the
hemolymph of ten silkworms fed with P. aeruginosa was collected
and analyzed for bacterial infection. Appropriate dilutions were
spread onto LB agar plates, incubated at 37 C overnight, and
CFUs were counted to quantify bacteria. Invasion of each strain
was analyzed in triplicate and the experiment was replicated in
triplicate. Additionally wild-type and mutant strains of bacteria
(103–107 CFU per silkworm) were injected into the hemolymph
of 10 silkworms at the ﬁfth-instar stage and viability monitored
as above.
2.9. Statistical analyses
Results are presented as the mean ± standard deviation (S.D.).
The data were subjected to a two-tailed t-test or one-way
ANOVA using Microsoft Excel 2010 (Microsoft, Redmond, WA,
USA). A P-value of P < 0.05 was considered statistically signiﬁcant.
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3.1. TFP are required for the penetration of P. aeruginosa through
Caco-2 cell monolayers
Investigating penetration through intestinal epithelial cell
monolayers using a DpilA and PAO1 strains demonstrated that fol-
lowing 3 h of infection bacteria of the DpilA strain could not pene-
trate Caco-2 cell monolayers while PAO1 strain could (Fig. 1A). The
penetration through Caco-2 cell monolayers by the DpilA strain
was rescued by introducing plasmids carrying the pilA gene
(Fig. 1A). Type IV pili are required for the association of P. aerugi-
nosawith human respiratory epithelial cells [22,30] and rabbit cor-
neal epithelial cells [32]. We performed association assays with
Caco-2 cells using the DpilA strain. There was no signiﬁcant differ-
ence in the numbers of bacteria of either PAO1 or the DpilA strains,
associated with Caco-2 cells (Fig. 1B). Furthermore, anti-PilA anti-
bodies did not affect the number of bacteria associated with Caco-2
cells (Fig. 1C), although they decreased penetration through Caco-2
cell monolayers (Fig. 1D).
3.2. Disruption of Caco-2 cell junctions is necessary for TFP-dependent
epithelial monolayer penetration
To penetrate the epithelial cell monolayer, bacteria must
cross two major barriers; the mucous and epithelial cell layers
[10–12]. To further examine the contribution of TFP in P. aerugi-
nosa to penetration through Caco-2 cell monolayers, we per-
formed an artiﬁcial mucin layer penetration assay using the
pilus mutant strain. A decrease in penetration of the ﬂagellar
ﬁlament mutant, DﬂiC, was consistent with previous ﬁndings
(Fig. 1E) [20]. However, there was no signiﬁcant difference
between PAO1 and the DpilA strains, which penetrated through
an artiﬁcial mucin layer (Fig. 1E). Next, to determine whether
P. aeruginosa can disrupt Caco-2 cell tight junctions through
the function of TFP, we measured TER following infection with
PAO1 and the DpilA strains. There was a steep drop in the TER
of monolayers infected with PAO1 and the DpilA/pilA strains
(Fig. 1F). There was no signiﬁcant change in the TER following
infection with the DpilA strain (Fig. 1F). TER is a sensitive mea-
sure of tight junctional barrier function and reﬂects the condi-
tion of tight junction formation. Western blot analysis revealed
that infection of Caco-2 cells with PAO1 or the DpilA/pilA strain
reduced the levels of expression of occludin protein at 4 h by
99% or 60%, respectively, and at 8 h by 99% or 98%, respectively,
relative to that observed following infection with the DpilA
strain (Fig. 1G). Overall, we observed a good correlation between
changes in TER (Fig. 1F) and the degradation of occludin protein
(Fig. 1G).
3.3. ExoS and TFP expression by the same bacterial cell is required for
penetration of Caco-2 monolayers by P. aeruginosa
P. aeruginosa can disrupt Caco-2 cell tight junctions using TFP
(Fig. 1A–G). A type III effector molecule, ExoS, facilitates P. aerugi-
nosa penetration through the epithelial barrier by impairing the
defense function of tight junctions [17,38]. To examine whether
ExoS and TFP in the same bacterial cell are necessary for disruption
of Caco-2 cell barriers, we measured the TER of Caco-2 cell mono-
layers following infection with a mixture of the DpilA and DexoS
strains. There was no signiﬁcant difference in TER changes among
the mixture, each single mutant, and double mutant strains indi-
vidually (Fig. 2A). Furthermore, the number of bacteria that
penetrated through Caco-2 cell monolayers was positively corre-
lated with the changes in TER (Fig. 2B). Our results showed thatonly P. aeruginosa expressing both ExoS and TFP in the same cell
can disrupt epithelial tight junctions.
3.4. TFP are necessary for the injection of ExoS into host cells
To determine whether injection of ExoS by P. aeruginosa into
epithelial cells is impacted by TFP-dependent cell penetration,
translocation of ExoS effectors was detected directly within living
host cells using the ﬂuorescent b-lactamase substrate CCF2/AM.
Green ﬂuorescence was not observed in Caco-2 cells after treat-
ment with CCF2/AM (data not shown), therefore we determined
b-lactamase activity using HeLa cells, as reported previously [36].
HeLa cells were infected with P. aeruginosa strains containing a
vector expressing an exoS/blaM (b-lactamase) fusion gene. CCF2
cleavage mediated by the translocated fusion protein induces the
disruption of ﬂuorescence resonance energy transfer and provokes
a shift from green to blue ﬂuorescence. Notably, deﬁciency of TFP
reduced both the number of cells positive for the blue ﬂuorescence
derived from the degradation products of CCF2 (Fig. 3A), and also
the ratio of blue to green ﬂuorescence intensity by approximately
50% (Fig. 3B).
3.5. TFP are required for the virulence of P. aeruginosa after oral
infection in silkworms
We performed an in vivo epithelial penetration assay using a
silkworm bacterial infection model to determine whether the
pilA and exoS genes are necessary for P. aeruginosa virulence after
oral infection [17]. The virulence of the DpilA, DexoS, and
DexoSDpilA strains after oral infection was signiﬁcantly attenuated
compared with the wild-type strain (Fig. 4A). We next directly
evaluated the ability of PAO1, the DpilA, DexoS, and DexoSDpilA
strains to penetrate the midgut barrier after oral administration.
As shown in Fig. 4B, the numbers of bacteria of the DpilA and
DexoS strains identiﬁed in the hemolymph at 6 h after oral infec-
tion were signiﬁcantly lower than that of PAO1 strain.
Additionally, the virulence after oral infection was similar between
single and double mutant strains (Fig. 4A and B). Moreover, silk-
worm viability following the injection of bacteria into the
hemolymph was similar among all strains at all inoculum doses
tested (103–107 CFU/silkworm) (Fig. 4C and data not shown).
4. Discussion
Our data showed that TFP are required for efﬁcient disruption of
tight junctions after adhesion to epithelial cells by P. aeruginosa
(Fig. 1A–G). Expression of both the type III effector ExoS and TFP
in the same cell is required for the disruption of the tight junctions
(Fig. 2A and B). Furthermore, ExoS injection by P. aeruginosa into
epithelial cells is impacted by TFP expression, allowing penetration
through the epithelial barrier (Fig. 3A and B). These in vitro ﬁnd-
ings were supported by results from an in vivo silkworm bacterial
infection model (Fig. 4A–C). Collectively, these results suggest that
TFP of P. aeruginosa are required for injection of the type III effector
ExoS into epithelial cells and the penetration of P. aeruginosa
through the epithelial barrier.
Deﬁciency of TFP reduced the amount of ExoS injected into
epithelial cells (Fig. 3A and B). PilT is a hexameric ATPase required
for bacterial type IV pilus retraction and surface twitching motility
[23,26–29]. The twitching motility of P. aeruginosa is important for
both P. aeruginosa cytotoxicity against epithelial cells and for viru-
lence in vivo [23,39]. Our data showed that the deletion of TFP did
not affect penetration through the artiﬁcial mucin layer and asso-
ciation with the epithelial cell surface (Fig. 1B and E). Based on our
data and these ﬁndings, we hypothesize that P. aeruginosa injects
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Fig. 1. Penetration of P. aeruginosa through epithelial cell monolayers in vitro. (A) Penetration of Caco-2 cell monolayers by wild-type P. aeruginosa (PAO1) and pilus mutant
strains. Caco-2 cells were infected, and the number of bacteria in the Transwell basolateral medium counted. The assay was performed in triplicate, and the results are
expressed as means ± S.D. ⁄P < 0.05 compared with TFP mutant strain (DpilA). (B) Association of wild-type and pilus mutant strains with Caco-2 cells. Bacteria were inoculated
onto the apical surface of Caco-2 cells. The number of associated bacteria was evaluated by lysis of Caco-2 cells with Triton X-100 after washing of the Transwell with DPBS.
The assay was performed in triplicate, and the results are expressed as means ± S.D. (C) P. aeruginosa strains were pretreated for 30 min with an anti-PilA antibody
(1.6  105 CFUs/40 lg of antibody) then inoculated onto the apical surface of the Caco-2 cells. The number of associated bacteria was evaluated by lysis of Caco-2 cells with
Triton X-100 after washing of the Transwell with DPBS. The assay was performed in triplicate, and the results are expressed as means ± S.D. (D) P. aeruginosa strains were
pretreated for 30 min with an anti-PilA antibody (1.6  105 CFUs/40 lg of antibody) then inoculated onto the apical surface of Caco-2 cells in Transwells, and the number of
bacteria in the basolateral medium counted. The assay was performed in triplicate, and the results are expressed as means ± S.D. ⁄P < 0.05 compared with the wild-type strain
(PAO1) without anti-PilA antibody treatment. (E) Penetration of the mucin layer by the wild-type and ﬂagellar and pilus mutant strains. Bacteria were loaded on top of 2%
bovine submaxillary mucin, and the number of bacteria in the bottom medium counted at 1 h. The assay was performed in triplicate, and the results are expressed as
means ± S.D. ⁄P < 0.05 compared with the wild-type strain (PAO1). (F) Changes in the TERs of Caco-2 cell monolayers. In the control, LB broth was added instead of bacteria.
The TER was measured at the indicated times in triplicate and is expressed as the average ± S.D. of the resistance multiplied by the area. ⁄P < 0.05 compared with TFP mutant
strain (DpilA). (G) Expression of occludin protein in Caco-2 cell monolayers infected with wild-type P. aeruginosa and pilus mutant strains. Caco-2 monolayers were infected
and incubated. The cell lysates were analyzed by Western blotting using anti-occludin and anti-b-actin antibodies.
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BA
Fig. 2. Penetration of P. aeruginosa through epithelial cell monolayers using ExoS and TFP. (A) Changes in the TERs of Caco-2 cell monolayers induced by wild-type P.
aeruginosa, the pilA gene mutant, the exoS gene mutant, the pilA and exoS genes double mutant, and a mixture of the pilA gene mutant and the exoS gene mutant strains. In the
control, LB broth was added instead of bacteria. The TER was measured at the indicated times in triplicate and is expressed as the average ± S.D. of the resistance multiplied by
the area. ⁄P < 0.05 compared with TFP mutant strain (DpilA). (B) Penetration of Caco-2 cell monolayers by wild-type P. aeruginosa, the pilA gene mutant, the exoS gene mutant,
the pilA and exoS genes double mutant, and mixture of the pilA gene mutant and the exoS gene mutant strains. Caco-2 cells were infected and the number of bacteria in the
basolateral medium counted. The assay was performed in triplicate, and the results are expressed as means ± S.D. ⁄P < 0.05 compared with TFP mutant strain (DpilA).
BA
Fig. 3. ExoS injection by P. aeruginosa into epithelial cells is impacted by TFP dependent cell penetration. (A) HeLa cells were infected for 4 h with the wild-type, wild-type
expressing ExoS-Bla, the pilus mutant, and the pilus mutant expressing ExoS-Bla. After incubation with b-lactamase substrate CCF2-AM, cells were observed by ﬂuorescence
microscopy using a 20 objective. (B) HeLa cells were infected for 4 h with the wild-type, wild-type expressing ExoS-Bla, the pilus mutant, and the pilus mutant expressing
ExoS-Bla. After incubation with the b-lactamase substrate CCF2-AM, blue (450 nm) and green (530 nm) ﬂuorescence intensities of the cells were measured with a
ﬂuorometric plate reader. The extent of ExoS-bla injection into cells is shown as the blue (450 nm)/green (530 nm) ﬂuorescence ratios. The assay was performed in triplicate,
and the results are expressed as means ± S.D. ⁄P < 0.05 compared with PAO1 harboring the pME6032 plasmid. #P < 0.05 compared with PAO1 expressing ExoS-Bla.
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cell surface. This hypothesis will be addressed in future studies.
P. aeruginosa has two major structures that contribute to moti-
lity: the ﬂagella [21,22] and TFP [23–25]. Moreover, other motility
mechanisms have been suggested in P. aeruginosa [40]. Our recent
report suggested that P. aeruginosa uses some form of motility
other than the ﬂagella to penetrate through the mucin layer,
because we observed mucin layer penetration even in the absence
of an intact ﬂagellum [20]. In this study, deﬁciency of TFP did not
affect penetration through the artiﬁcial mucin layer and asso-
ciation with the epithelial cell surface (Fig. 1B–E). Taken together,
TFP are not required for penetration of mucin layers. Therefore,
further studies are necessary to better understand the motility
used for penetration of mucin layers.The ﬂagella and TFP are adhesins for host cells [22]. Other adhe-
sins have been identiﬁed, including the cup ﬁmbrial adhesins [41]
and lectins PA-IL (LecA) and PA-IIL (LecB) [42]. In this study, we
observed association of bacteria with Caco-2 cells even in the
absence of intact pili. Taken together, P. aeruginosa can bind to
Caco-2 cells using other adhesion systems. However, further stud-
ies are necessary to understand the role of P. aeruginosa adhesins in
adherence to Caco-2 cells.
P. aeruginosa can adhere to human respiratory [22] and rabbit
corneal [32] epithelial cells using TFP. However, we observed that
there was no difference in association with Caco-2 human intesti-
nal cells between bacteria of the wild-type and the pilus mutant
strains (Fig. 1B and C). This may be cell speciﬁc. For example, if
asialo-GM1, to which the pilin binds [24,25,33], varies in
BA
C
Fig. 4. Pili are essential for P. aeruginosa virulence in silkworms because of its ability to mediate penetration through the midgut epithelial barrier. (A) Comparison of the
virulence of wild-type P. aeruginosa, pilA gene mutant, exoS gene mutant, and the pilA and exoS genes double mutant strains following oral administration to 10 silkworms.
Saline was used as a control. (B) Numbers of bacteria in the hemolymph at 6 h after oral administration of wild-type P. aeruginosa, pilA gene mutant, exoS gene mutant, and the
pilA and exoS genes double mutant strains to 10 silkworms. The assay was performed in duplicate, and the results are expressed as means ± S.D. ⁄P < 0.05 compared with the
wild-type strain (PAO1). (C) Comparison of the virulence of wild-type P. aeruginosa, pilA gene mutant, exoS gene mutant, and the pilA and exoS double mutant strains following
injection into the hemolymph (103 CFU per silkworm) of 10 silkworms. Saline was used as a control.
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cells. However, the reasons for the inability of P. aeruginosa to asso-
ciate with Caco-2 cells via TFP remain unclear.
Fig. 4A and B showed that TFP are required for P. aeruginosa
translocation from the gut to the hemolymph of silkworms.
Fig. 4C showed that silkworm viability following the injection of
bacteria into the hemolymph was similar between PAO1 and the
DpilA strains. Furthermore, there was a positive correlation
between the number of bacteria in the hemolymph and the mor-
tality rate of silkworms after direct injection of P. aeruginosa into
hemolymph [43–45]. Therefore, we conclude that the mortality
of silkworms following oral infection by the wild-type strain is at
least partially dependent upon the ability of the bacteria to pene-
trate efﬁciently through the gut epithelial barrier in a TFP-depen-
dent manner. Additionally, because there was no signiﬁcant
difference between groups after infection with the DpilA, DexoS,
and DpilAexoS strains (Fig. 4A–C), we hypothesize that both TFP
and ExoS are necessary for the establishment of gut-derived sepsis
after oral infection by the same pathway.
In summary, our study using in vitro cultured epithelial cells
and an in vivo silkworm bacterial infection model, showed that
the P. aeruginosa PAO1 strain requires TFP for the injection of the
type III effector molecule ExoS into epithelial cells by the type IIIsecretion system, thereby enabling penetration of intestinal
epithelial barriers. Further studies will be required to clarify the
contribution of TFP to P. aeruginosa penetration through epithelial
tissues, although these ﬁndings may lead to new therapeutic
strategies for P. aeruginosa gut-derived sepsis.
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